相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation
Toshiaki Iba et al.
ANESTHESIOLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Alexander E. Gorbalenya et al.
NATURE MICROBIOLOGY (2020)
Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence
Julien Poissy et al.
CIRCULATION (2020)
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics
Jinnong Zhang et al.
LANCET RESPIRATORY MEDICINE (2020)
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19
Rong Qu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia
David Lillicrap
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia
Ling Lin et al.
EMERGING MICROBES & INFECTIONS (2020)
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability
Hong-Ru Chen et al.
PLOS PATHOGENS (2018)
Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis
Jennifer M. Hanify et al.
JOURNAL OF CRITICAL CARE (2017)
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
Hin Chu et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Molecular mechanisms of Ebola virus pathogenesis: focus on cell death
L. Falasca et al.
CELL DEATH AND DIFFERENTIATION (2015)
Human Ebola virus infection results in substantial immune activation
Anita K. McElroy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A Synthetic Serine Protease Inhibitor, Nafamostat Mesilate, Is a Drug Potentially Applicable to the Treatment of Ebola Virus Disease
Hidekazu Nishimura et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Hemostatic derangement in dengue hemorrhagic fever
Ampaiwan Chuansumrit et al.
THROMBOSIS RESEARCH (2014)
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Lisa E. Gralinski et al.
MBIO (2013)
Pathogenesis of the Viral Hemorrhagic Fevers
Slobodan Paessler et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
Nadia Wauquier et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Thrombopoietin levels increased in patients with severe acute respiratory syndrome
Mo Yang et al.
THROMBOSIS RESEARCH (2008)
Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-β signaling
Xingang Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro
Manisha Gupta et al.
VIROLOGY (2007)
Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters
Toshiaki Iba et al.
SHOCK (2006)
Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets
ZP He et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2005)
Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection
YH Yang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Thrombocytopenia in patients with severe acute respiratory syndrome (review)
M Yang et al.
HEMATOLOGY (2005)
Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)
KF To et al.
JOURNAL OF PATHOLOGY (2004)
Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys
TW Geisbert et al.
LANCET (2003)
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
RSM Wong et al.
BRITISH MEDICAL JOURNAL (2003)
A major outbreak of severe acute respiratory syndrome in Hong Kong
N Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
